Skip to content
No results
  • Home
  • News
  • Press Releases
  • Business
  • Technology
  • Research
  • Regulatory
  • Events and Conferences
  • About Us
  • Contact Us
  • About Us
  • Contact Us
The Pharma Data
  • News
  • Press Releases
  • Business
  • Technology
  • Research
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Research

Clarametyx Biosciences Reports Advancements in CMTX-101 Antibody Therapy for Cystic Fibrosis Infections

  • The Pharma Data
  • October 18, 2024

Clarametyx Biosciences Moves Forward with Phase 2a Study of CMTX-101 for Cystic Fibrosis Infections Clarametyx Biosciences, Inc. has successfully completed the Phase 1b portion of its clinical trial for CMTX-101,…

Read MoreClarametyx Biosciences Reports Advancements in CMTX-101 Antibody Therapy for Cystic Fibrosis Infections
  • Press Releases

ModMed Unveils Cutting-Edge Solutions for Ophthalmology Practices at AAO 2024

  • The Pharma Data
  • October 18, 2024

ModMed Empowers Ophthalmology Practices with Innovative Solutions at AAO 2024 ModMed® is excited to announce its participation in the American Academy of Ophthalmology (AAO) 2024 conference, taking place from October…

Read MoreModMed Unveils Cutting-Edge Solutions for Ophthalmology Practices at AAO 2024
  • Press Releases

DNA Script Names Marc Montserrat CEO to Propel Long-Term Growth for Enzymatic DNA Synthesis

  • The Pharma Data
  • October 18, 2024

DNA Script Appoints Marc Montserrat as CEO, Thomas Ybert Transitions to Chief Scientific Officer DNA Script, a leader in enzymatic DNA synthesis, has appointed Marc Montserrat as its new Chief…

Read MoreDNA Script Names Marc Montserrat CEO to Propel Long-Term Growth for Enzymatic DNA Synthesis
  • Business

BenevolentAI Appoints Kenneth Mulvany as Executive Chairman

  • The Pharma Data
  • October 18, 2024

BenevolentAI benoemt Kenneth Mulvany tot uitvoerend voorzitter om AI-gestuurde geneesmiddelenontwikkeling te versnellen BenevolentAI, een toonaangevend bedrijf dat geavanceerde AI toepast voor de ontdekking en ontwikkeling van biofarmaceutische geneesmiddelen, heeft vandaag…

Read MoreBenevolentAI Appoints Kenneth Mulvany as Executive Chairman
  • Research

Kezar Life Sciences Shares Positive PORTOLA Trial Safety Review for Zetomipzomib

  • The Pharma Data
  • October 18, 2024

Kezar Life Sciences Updates on Clinical Trials for Zetomipzomib Kezar Life Sciences, Inc. (Nasdaq: KZR), a biotechnology company focused on developing innovative therapeutics for immune-mediated diseases, has provided important updates…

Read MoreKezar Life Sciences Shares Positive PORTOLA Trial Safety Review for Zetomipzomib
  • Business

Peripheral Vascular Devices Market Forecast 2024-2032: Key Players Include Abbott and Medtronic

  • The Pharma Data
  • October 18, 2024

The “Peripheral Vascular Devices Market Report, Forecast by Device Type, Country and Company Analysis 2024-2032” has been added to ResearchAndMarkets.com. The global peripheral vascular devices market is projected to grow…

Read MorePeripheral Vascular Devices Market Forecast 2024-2032: Key Players Include Abbott and Medtronic
  • Press Releases

HeartBeam Appoints Robert Eno as CEO Ahead of U.S. Commercialization

  • The Pharma Data
  • October 18, 2024

HeartBeam Appoints Robert Eno as CEO, Focused on U.S. Commercialization Industry leader brings extensive experience in developing go-to-market strategies for breakthrough products and driving growth HeartBeam, Inc. (NASDAQ: BEAT), a…

Read MoreHeartBeam Appoints Robert Eno as CEO Ahead of U.S. Commercialization
  • Business

Kezar Board Rejects Unsolicited Concentra Proposal and Implements Short-Term Stockholder Rights Plan

  • The Pharma Data
  • October 18, 2024

Kezar Life Sciences Board Unanimously Rejects Concentra’s Acquisition Proposal and Implements Limited Duration Stockholder Rights Plan Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company focused on developing novel…

Read MoreKezar Board Rejects Unsolicited Concentra Proposal and Implements Short-Term Stockholder Rights Plan
  • Press Releases

Nordic Group Launches LACRIFILL® Canalicular Gel for Dry Eye at AAO 2024

  • The Pharma Data
  • October 18, 2024

Nordic Pharma Introduces LACRIFILL Canalicular Gel for Dry Eye at AAO 2024 Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., is showcasing LACRIFILL Canalicular Gel, a novel therapy for…

Read MoreNordic Group Launches LACRIFILL® Canalicular Gel for Dry Eye at AAO 2024
  • Press Releases

Wisp Introduces Comprehensive Weight Care Program for Women Facing Hormonal Imbalances

  • The Pharma Data
  • October 18, 2024

Wisp Expands Menopause Solutions and Launches Weight Care Vertical for Women Wisp, the leading women’s telehealth company in the U.S. dedicated to sexual and reproductive health, has announced a significant…

Read MoreWisp Introduces Comprehensive Weight Care Program for Women Facing Hormonal Imbalances
  • Press Releases

GE HealthCare’s New Hospital Pulse Tile Secures First Major Academic Medical Center Customer

  • The Pharma Data
  • October 18, 2024

GE HealthCare Unveils Hospital Pulse Tile for Command Center Software GE HealthCare (Nasdaq: GEHC) has announced the launch of Hospital Pulse, a new tile within its Command Center Software Platform.…

Read MoreGE HealthCare’s New Hospital Pulse Tile Secures First Major Academic Medical Center Customer
  • Research

Transcarent Chosen to Enhance Evernorth’s Comprehensive Cancer Care Experience

  • The Pharma Data
  • October 18, 2024

Evernorth and Transcarent Collaborate to Deliver Unmatched Cancer Care, Navigation, and Support Services Starting January 1, 2025 Transcarent, known as the One Place for Health and Care, has been selected…

Read MoreTranscarent Chosen to Enhance Evernorth’s Comprehensive Cancer Care Experience
PrevNext

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • EmeraNova™ Strengthens Innovation Leadership with Launch of New Accelerator ProgramNovember 5, 2026
  • Global Healthy Living Foundation Highlights Advances in Myositis and Polymyalgia Rheumatica Research at ACR Convergence 2026November 5, 2026
  • Polaris Rx Chosen by Bristol Myers Squibb to Distribute ZENBEXUS™, the First FDA-Approved CELMoD Treatment for Multiple MyelomaNovember 5, 2026
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.